Breast fibroepithelial lesions are underpinned by recurrent MED12 exon 2 somatic mutations in stromal cells (59–67% of fibroadenomas and 45–67% of PTs), particularly in fibroadenomas and benign PTs. The gene discussed is MED12; the disease is Fibroadenoma.